About Philip Amrein, MD
Clinical Interests:
- Acute Leukemia
- Chronic leukemia
- Myelodysplasia
- Myeloproliferative neoplasms
Treats:
- Adult
Locations
Mass General Cancer Center: Hematology/Oncology BMT Program
100 Blossom Street
Boston, MA 02114
Phone: 617-724-3456
Phone: 617-726-8748
Fax: 617-724-2525
Medical Education
- MD, Johns Hopkins University School of Medicine
- Residency, Yale Waterbury Hospital
- Fellowship, Massachusetts General Hospital
American Board Certifications
- Internal Medicine, American Board of Internal Medicine
- Medical Oncology, American Board of Internal Medicine
Accepted Insurance Plans
- Aetna
- Beech Street
- Blue Cross Blue Shield
- Blue Cross Blue Shield Medicare
- Cigna
- Commonwealth Care Alliance
- Coventry
- Fallon Health
- Harvard Pilgrim Health Care
- Humana
- Maine Community Health Options
- Mass General Brigham Health Plan
- MassHealth
- Medicaid CT
- Medicaid ME
- Medicaid NH
- Medicaid NY
- Medicaid RI
- Medicaid VT
- Medicare
- Medicare ACO
- Multiplan
- Railroad Medicare
- Senior Whole Health
- TriCare
- Tufts Health Plan
- United Health Care
- Wellpoint
- WellSense
- WellSense NH
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Publications
-
Select Publications:
- Schiffer CA,...Amrein PC,..."A double-blind, placebo-controlled trial of pegylated recombinant MGDF as an adjunct to induction and consolidation therapy to patients with acute myeloid leukemia". Blood 2000;95:2530-2535.
- Moore JO,...Amrein PC,...."Sequential multiagent chemotherapy is not superior to high-dose cytarabine alone as postremission intensification therapy for acute myeloid leukemia in adults under 60 years of age: CALGB study 9222". Blood 2005;105:3420-3427.
- Attar EC,...Amrein PC. "Phase I and pharmacokinetic study of bortezomib in combination with idarubicin and cytarabine in patients with AML". Clinical Cancer Research 2008;14:1446-1454.
- DeAngelo D,...Amrein PC,..."A multicenter phase II study using a dose intensified pediatric regimen in adults with untreated acute lymphocytic leukemia". Blood (ASH abstract #580) 2007.
- Amrein PC, et al. "Dasatinib has activity in relapsed/refractory CLL/SLL". Blood (ASH abstract #3162) 2008.
they were very helpful and informative.
I can say they are the best
The care I received from the Doctor and nurses is always a 10
My experience with this provider was excellent in every aspect. Doctor Amrein's demeanor, knowledge, professionalism and interaction with me exceed my expectations.
The team worked efficiently and carefully. Dr. Amrein kept me well-informed. I appreciate the good care taken.
He was great. [redacted]
Dr. Amrein could not have been more accommodating. He listened to my concerns and took the time to carefully explain my situation and what the game plan would be.
Very helpful with the many questions we had
Very knowledgeable, thoughtful, kind and caring. Very thorough.
Excellent in every way.